30 results on '"Zanaboni, Laura"'
Search Results
2. Bone disease in adult patients with β-thalassaemia major: a case–control study
3. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients
4. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major
5. Bone demineralization in adult thalassaemic patients: contribution of GH and IGF-I at different skeletal sites
6. Growth hormone deficiency (GHD) in adult thalassaemic patients
7. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
8. Human CD34+ Cells from Different Sources Disclose a Specific Stemness Signature
9. Intrinsic Molecular Features of Human Hematopoietic Stem Cells from Different Sources Define Their Specific Functional Properties
10. Serum lipoproteins in diabetes: Relation of alpha-lipoprotein level to therapy
11. Prevalence of hypothyroidism in a large series of adult thalassemic patients
12. The Challenge Of HSCs Procurement For Gene Therapy: Exploring Plerixafor As Mobilization Agent
13. Plerixafor Single Agent for Autologous Stem Cells Mobilization and Collection in Adult Thalassemic Patients: Towards the Assessment of the Suitable Hematopoietic Stem Cell Source for Gene Therapy of Beta-Thalassemia.
14. Abnormal Fundus Autofluorescence Results of Patients in Long-term Treatment with Deferoxamine
15. Thyroid Cancer in β-Thalassemia
16. Bone disease in adult patients with β-thalassaemia major: a case–control study
17. Improvement of Cardiac Function and Cardiac Volumes in Patients Treated with Deferasirox
18. Neridronate (NE) for the Treatment of Osteoporosis In Patients with β-Thalassemia: Results from an Italian Multicenter Randomized, Open Label, Phase II Trial
19. Cardiac Iron Overload Assessed by T2* Magnetic Resonance (CMR) In Thalassemia Major Patients Treated with Different Iron Chelators
20. The pituitary–adrenal axis in adult thalassaemic patients
21. Liver Fibrosis Assessed by Transient Elastography in Adult Thalassemia Intermedia Patients
22. A 5-Years Follow-up in Deferasirox Treatment: Improvement of Cardiac and Hepatic Iron Overload and Amelioration in Cardiac Function in Thalassemia Major Patients
23. Molecular Analysis of Alpha Hemoglobin Stabilizing Protein (AHSP) in Caucasian Patients with different Beta-Thalassemia Phenotypes.
24. An update on iron chelation therapy.
25. Human CD34+Cells from Different Sources Disclose a Specific Stemness Signature
26. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone
27. Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone.
28. An update on iron chelation therapy.
29. Pregnant women affected by thalassemia major: a controlled study of traits and personality.
30. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.